抗癫痫药物控制癫痫发作活动的双重机制

Dual mechanism of Anti-Seizure Medications in controlling seizure activity

摘要 Abstract

背景:抗癫痫药物(ASMs)可以减少癫痫发作的持续时间,但其确切的作用机制尚不清楚。具体而言,目前尚不清楚ASMs是通过简单地将现有的癫痫活动压缩到更短的时间内来缩短发作,还是通过选择性地抑制某些癫痫活动模式来实现这一效果。方法:我们分析了28名正在接受ASM减量治疗的癫痫患者记录的457次癫痫发作的颅内脑电图(iEEG)。除了测量癫痫发作的发生率和持续时间外,我们还基于空间特性和频率功率特征对不同的癫痫活动模式(状态)进行了分类,并将其与不同ASM水平相关联。结果:我们发现降低ASM水平会导致癫痫发作频率增加(r = 0.87, p < 0.001)以及癫痫发作持续时间延长($\beta$ = -0.033, p < 0.001),这与先前的研究结果一致。进一步分析显示,癫痫发作延长存在两种不同的机制:新癫痫模式的出现——在约40%的患者中,ASM减量揭露出额外的癫痫活动状态,包含这些“减量诱导状态”的癫痫发作明显更长(r = 0.49, p < 0.001)。现有癫痫模式的延长——即使在没有减量诱导状态的癫痫发作中,较低的ASM水平仍然导致发作持续时间延长约12-224%,具体取决于ASM剂量和减量程度($\beta$ = -0.049, p < 0.001)。结论:ASMs通过两种机制影响癫痫发作:它们以全有或全无的方式抑制特定的癫痫活动模式(状态),并限制其他癫痫模式的持续时间。这些发现突显了ASMs在调节癫痫中的复杂作用,并可能为癫痫管理提供个性化的给药策略。这些发现也可能有助于理解ASMs对认知和情绪的影响。

Background: Anti-seizure medications (ASMs) can reduce seizure duration, but their precise modes of action are unclear. Specifically, it is unknown whether ASMs shorten seizures by simply compressing existing seizure activity into a shorter time frame or by selectively suppressing certain seizure activity patterns. Methods: We analysed intracranial EEG (iEEG) recordings of 457 seizures from 28 people with epilepsy undergoing ASM tapering. Beyond measuring seizure occurrence and duration, we categorized distinct seizure activity patterns (states) based on spatial and frequency power characteristics and related these to different ASM levels. Results: We found that reducing ASM levels led to increased seizure frequency (r = 0.87, p < 0.001) and longer seizure duration ($\beta$ = -0.033, p < 0.001), consistent with prior research. Further analysis revealed two distinct mechanisms in which seizures became prolonged: Emergence of new seizure patterns - In approx. 40% of patients, ASM tapering unmasked additional seizure activity states, and seizures containing these 'taper-emergent states' were substantially longer (r = 0.49, p < 0.001). Prolongation of existing seizure patterns - Even in seizures without taper-emergent states, lower ASM levels still resulted in approx. 12-224% longer durations depending on the ASM dosage and tapering ($\beta$ = -0.049, p < 0.001). Conclusion: ASMs influence seizures through two mechanisms: they (i) suppress specific seizure activity patterns (states) in an all-or-nothing fashion and (ii) curtail the duration of other seizure patterns. These findings highlight the complex role of ASMs in seizure modulation and could inform personalized dosing strategies for epilepsy management. These findings may also have implications in understanding the effects of ASMs on cognition and mood.